High Mutability of the Tumor Suppressor Genes RASSF1 and RBSP3 (CTDSPL) in Cancer

Autor: Eleonora A. Braga, George Klein, Blinov Vm, Ingemar Ernberg, Tatiana Eshchenko, Lev L. Kisselev, Eugene R. Zabarovsky, Julia Kobliakova, Veronica I. Zabarovska, Vladimir I. Kashuba, Michael I. Lerman, Tatiana V. Pavlova, Jingfeng Li, Yi Xin Zeng, Alexey S. Kutsenko, V. N. Senchenko, Fuli Wang, Olga Vorontsova, Elvira V. Grigorieva, Alexei Protopopov, Klas Haraldson, Surya Pavan Yenamandra, Igor Kuzmin
Rok vydání: 2009
Předmět:
Somatic cell
lcsh:Medicine
Mice
SCID

medicine.disease_cause
Polymerase Chain Reaction
Mice
Neoplasms
Mutation frequency
Oncology/Hematological Malignancies
lcsh:Science
Genetics and Genomics/Genetics of Disease
Oncology/Renal Cancer
Genetics and Genomics/Medical Genetics
Expressed Sequence Tags
Genetics
Mutation
Genome
Multidisciplinary
Escherichia coli Proteins
Founder Effect
Kidney Neoplasms
Oncology/Breast Cancer
Computational Biology/Sequence Motif Analysis
Oncology/Gynecological Cancers
Research Article
DNA
Bacterial

DNA
Complementary

APOBEC-1 Deaminase
Somatic hypermutation
Biology
Cell Line
Cell Line
Tumor

Cytidine Deaminase
medicine
Animals
Humans
Genetics and Genomics/Cancer Genetics
Carcinoma
Renal Cell

Gene
Oncology/Lung Cancer
Cell Proliferation
Tumor Suppressor Proteins
Point mutation
lcsh:R
Computational Biology
Cancer
medicine.disease
Clone Cells
Hematopoiesis
Cancer cell
lcsh:Q
Zdroj: PLoS ONE, Vol 4, Iss 5, p e5231 (2009)
PLoS ONE
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0005231
Popis: Background Many different genetic alterations are observed in cancer cells. Individual cancer genes display point mutations such as base changes, insertions and deletions that initiate and promote cancer growth and spread. Somatic hypermutation is a powerful mechanism for generation of different mutations. It was shown previously that somatic hypermutability of proto-oncogenes can induce development of lymphomas. Methodology/Principal Findings We found an exceptionally high incidence of single-base mutations in the tumor suppressor genes RASSF1 and RBSP3 (CTDSPL) both located in 3p21.3 regions, LUCA and AP20 respectively. These regions contain clusters of tumor suppressor genes involved in multiple cancer types such as lung, kidney, breast, cervical, head and neck, nasopharyngeal, prostate and other carcinomas. Altogether in 144 sequenced RASSF1A clones (exons 1–2), 129 mutations were detected (mutation frequency, MF = 0.23 per 100 bp) and in 98 clones of exons 3–5 we found 146 mutations (MF = 0.29). In 85 sequenced RBSP3 clones, 89 mutations were found (MF = 0.10). The mutations were not cytidine-specific, as would be expected from alterations generated by AID/APOBEC family enzymes, and appeared de novo during cell proliferation. They diminished the ability of corresponding transgenes to suppress cell and tumor growth implying a loss of function. These high levels of somatic mutations were found both in cancer biopsies and cancer cell lines. Conclusions/Significance This is the first report of high frequencies of somatic mutations in RASSF1 and RBSP3 in different cancers suggesting it may underlay the mutator phenotype of cancer. Somatic hypermutations in tumor suppressor genes involved in major human malignancies offer a novel insight in cancer development, progression and spread.
Databáze: OpenAIRE